The medial habenula (MHb) exhibits exceptionally high levels of nicotinic acetylcholine receptors (nAChRs), but it remains unclear whether all expressed nAChR subunit mRNAs are translated to form functional receptors. In particular a4 subunits have not been reported to have any functional role, despite strong a4 mRNA expression in the ventrolateral MHb. We studied a strain of knock-in mice expressing fluorescent a4 * nAChRs (a4YFP), as well as a knock-in strain expressing hypersensitive a4 * nAChRs (a4L9 0 A). In a4YFP mice, there was strong fluorescence in the ventrolateral MHb. In hypersensitive a4L9 0 A mice, injections of a low dose of nicotine (0.1 mg/kg) led to strong c-fos expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice. In MHb slice recordings, ventrolateral neurons from a4L9 0 A mice, but not from WT mice, responded robustly to nicotine (1 mM). Neurons in the medial aspect of the MHb had >10-fold smaller responses. Thus a4 * nAChRs contribute to the selective activation of a subset of MHb neurons. Subunit composition analysis based on gain-offunction knock-in mice provides a useful experimental paradigm.
Introduction
Nicotinic acetylcholine receptors (nAChRs) are promising drug targets in the treatment of several CNS disorders such as Alzheimer's disease, schizophrenia, neuropathic pain and substance abuse (Arneric et al., 2007) . Successful treatments will require discovery of agents that select among multiple subtypes of nAChRs (Role, 1992; Gotti et al., 2007) . To choose appropriate drugs and to avoid offtarget effects, one must understand how each nAChR is distributed among cell types and contributes to neuronal function and behavior. Despite much progress (e.g., Luetje, 2004) , these tasks remain challenging because we lack tools to unambiguously identify the subunit make-up of particular nAChRs. Novel subunit-specific toxins (Janes, 2005) and gene-specific knockout models (CorderoErausquin et al., 2000; Picciotto et al., 2001 ) have confirmed roles for certain subunits; however, the expression of multiple subunits within individual cells renders subunit compensation a possibility in knockout studies (e.g., Brussaard et al., 1994) .
Definitive identification of nAChR subtypes is especially problematic for neurons in the medial habenula (MHb), which expresses the highest levels of nAChRs in the brain (Marks et al., 1998) . MHb expresses mRNAs encoding several different subunits (a3-a7 and b2-b4) (Sheffield et al., 2000) . Pharmacological data suggest that heteromeric nAChRs, composed of a minimum of a3 and b4 subunits (a3b4 * ), are a major functional subtype in this nucleus (Mulle and Changeux, 1990; Quick et al., 1999; Perry et al., 2002; Whiteaker et al., 2002) . While the function(s) of this small epithalamic nucleus is not well understood (Lecourtier and Kelly, 2007) , a3b4 * -nAChRs are important for sensitization and selfadministration of opioids in rats (Glick et al., 2006; Taraschenko et al., 2007) . It is not yet known how other nAChR subunits contribute to the heterogeneous MHb nAChR receptor population (Connolly et al., 1995) . This paper examines the expression of functional a4 subunits, whose mRNA is also found within the MHb (Wada et al., 1989; Pauly et al., 1996) . a4 * nAChRs are thought to be necessary and sufficient for the expression of behaviors underlying nicotine addiction including reward, tolerance and sensitization (Tapper et al., 2004; Maskos et al., 2005) , but not withdrawal (Salas et al., 2004) . Also, a4b2 * receptors are associated with monogenic epilepsies (Phillips et al., 1995; Fonck et al., 2003 Fonck et al., , 2005 ).
Here we combined conventional approaches with genetic strategies that use two lines of knock-in mice. One line expresses fluorescently tagged a4 * nAChRs (a4YFP, Nashmi et al., 2007) ; the other expresses hypersensitive a4 * nAChRs bearing a leucine to alanine substitution at the M2 9 0 position (a4L9 0 A, Tapper et al., 2004; Fonck et al., 2005) . The results show the distribution and function of MHb a4 * nAChRs.
Materials and methods
Experiments involving mice were performed following the guidelines established by each institution's Animal Care Committee. Mutant mouse lines were genotyped by PCR analysis of tail DNA.
2.1. In situ hybridization of the a4 subunit mRNA in MHb of C57BL/6J mice A mouse DNA template encoding the third intracellular loop of the a4 nAChR subunit was prepared by RT-PCR amplification of mRNA from a mouse septal neuroblastoma cell line (SN56). The mouse DNA templates were subcloned into pBluescript SK(þ) and sequenced. The genomic DNA region for a4 had a total of 743 bp (bases 1046-1789). cRNA riboprobes labeled with [ 
Generation and analysis of a4YFP mice
Generation and phenotypic characterization of a4YFP knock-in mice have been described (Nashmi et al., 2007) . Previous studies in vitro and in the knock-in mice (Nashmi et al., 2007) showed that YFP inserted in the M3-M4 cytoplasmic loop did not alter the function or distribution of a4 * receptors compared to WT. For fluorescence analysis, mice were sacrificed and fixed by intracardial perfusion with 4% paraformaldehyde in phosphate-buffered saline (PBS). Brain coronal sections, 30 mm thick, were sliced with a cryostat and mounted onto glass slides. Sections of the middle portion of the MHb along its rostro-caudual axis were selected for these studies. Fluorescence images were collected from a microscope equipped with a spectrally resolved detector array (LSM 510 Meta; Zeiss, Germany). Images (12-bit intensity resolution over 1024 Â 1024 pixels) were collected at wavelengths between 495 and 602 nm with bandwidths of 10.7 nm during excitation of YFP with the 488 nm line of an argon laser (1-10%; 23-114 mW). Specific YFP fluorescence was isolated from background autofluorescence at each pixel with a linear unmixing algorithm based on two reference spectra: fluorescence of YFP and autofluorescence of WT brain sections.
C-fos immunoreactivity in nicotine-injected mice
Generation and phenotypic characterization of a4L9 0 A mice have been previously described (Tapper et al., 2004; Fonck et al., 2005; Shao et al., 2008) . WT and homozygous a4L9 0 A mice were subcutaneously injected with 0.1 (n ¼ 5/genotype), 2 (n ¼ 3/genotype) or 10 (n ¼ 3 WT) mg/kg nicotine 1.5 h prior to being euthanized with 2-bromo-2-chloro-1,1,1-trifluoroethane. As a negative control, three WT and three a4L9 0 A mice were injected with saline 1.5 h prior to euthanasia. Mice were perfused through the left ventricle with 0.1% heparin in PBS (10 ml) followed by 4% paraformaldehyde (20 ml). Brains were equilibrated in 25% sucrose before 30 mm thick coronal sections were cut with a cryostat. Brain sections from a4L9 0 A and WT mice were simultaneously processed. Free-floating sections were reacted against c-fos polyclonal antibody diluted 1:500 (Santa Cruz biotechnology, CA). The antigen-antibody signal was detected with a secondary antibody, amplified with an avidin-biotin reaction (Vector laboratories, Burlingame, CA) and visualized with diaminobenzidine (Sigma-Aldrich, Saint-Louis, MO). Initial observations indicated that the distribution pattern of c-fos positive cells was similar among sections from the rostral, middle and caudal regions of the MHb. Thus final quantification and statistical analysis were performed on matching (WT versus a4L9 0 A) sections from the middle portion of the MHb, as for the fluorescence measurements on a4YFP mice. We compared two cell-counting methodologies: (i) unbiased stereology using Stereo Investigator software (mbf-bioscience, Williston, VT) and (ii) direct cell counting. The average number of c-fos positive cells counted within MHb sections was similar for the two methods. However, the standard deviation rendered by the unbiased stereology method was larger compared to direct counts. Unbiased stereology contributed more variability to our measurements because there was an uneven distribution of c-fos positive cells in the MHb. In other words, there were cell counts from quadrants in regions with many c-fos positive cells as well as counts from quadrants with very few or no positive cells.
Consequently, we performed our analysis based on direct cell counts. Because the variance in the data was not randomly distributed in the saline-treated groups, a non-parametric test, Kruskal-Wallis, followed by Tukey's test for comparisons, was used to compare treatment groups (SigmaStat by Systat, San Jose, CA).
Patch-clamp recording in brain slices
WT and homozygous a4L9 0 A mice were anesthetized with CO 2 and decapitated.
Brains were removed and a block of tissue containing the habenula was placed in ice-cold artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl, 126; NaHCO 3 , 26; KCl, 2.5; NaH 2 PO 4 , 1.25; MgCl 2 , 1; CaCl 2 , 2; D-glucose, 25; kynurenic acid, 1; bubbled with 95% CO 2 /5% O 2 . The tissue was glued to the slicing platform of a DSK-1000 vibratome tissue slicer (Dosaka EM, Kyoto, Japan), and immersed in ACSF. Four to six coronal slices containing the MHb were maintained for 1-8 h in the prechamber, then individually transferred to a recording chamber mounted to the fixed stage of an Olympus microscope equipped with DIC optics and an infra-red-sensitive camera and continuously perfused with ACSF at 1-2 ml min À1 . MHb cell recordings were obtained from either the ventromedial area close to the 3rd ventricle or the ventrolateral area adjacent to the lateral habenula (see fluorescence in Fig. 1 ). Patch pipettes contained (in mM): K-or Cs-gluconate, 144; HEPES, 10; EGTA, 0.2; MgCl 2 , 3; pH 7.2. Series resistance (uncompensated) and whole-cell capacitance were monitored throughout the recording. Voltage-clamp currents were recorded using an AxoPatch (Molecular Devices Axon Instruments) amplifier, filtered at 1 kHz, digitized at 2 kHz and stored to disk using pCLAMP (Axon) for off-line analysis. Neurons were included in the analysis if there was <100 pA leak at -50 mV. Nicotine (diluted in ACSF) was applied by pressure ejection (1-3 psi, 10 s) using a micropipette positioned <20 mm from the cell. In some experiments, blockers were added to the ACSF to suppress other responses: tetrodotoxin (200 nM); D-AP5 (10-20 mM); CNQX (10 mM).
Results

Distribution of a4 mRNA and expression of a4YFP receptors
The distribution of a4 mRNA and a4 protein was assessed by in situ hybridization in C57BL/6J mice and by fluorescence of tissue from a4YFP mice, respectively. The signal from hybridized a4 mRNA was concentrated in the ventrolateral region of the MHb, whereas no signal was detected in the dorsal-medial aspect of the structure ( Fig. 1A and B) . A similar distribution pattern of a4 mRNA within the MHb of C57BL/6J mice appears in the data of Wada et al. (1989) and of the Allen Brain Atlas (www.brain-map.org).
The brains of a4YFP mice displayed YFP signal in several areas (Nashmi et al., 2007) . The highest intensity was found in the MHb. YFP fluorescence was localized to the ventrolateral portion of the MHb, with a distribution pattern strongly resembling that of the in situ hybridization study ( Fig. 1C and E) . a4 * nAChRs were also visualized in projection fibers of the fasciculus retroflexus (fr; Fig. 1C and D) ; other images show that the YFP fluorescence persists as these fibers reach the interpeduncular nucleus. As negative control, tissue from WT littermates of a4YFP mice showed no YFP fluorescence (data not shown).
The a4YFP mice were developed, and have been previously exploited, to provide quantitative data about protein levels. Thus, when a4YFP expression in various brain areas (Nashmi et al., 2007) is compared with the known expression of L-[ 3 H] nicotine binding in those same brain regions (Marks et al., 1992) , a4YFP expression correlates significantly with nicotine binding (r ¼ 0.80; p ¼ 0.0005; Fig. 2A ), as expected if a4 subunits are a major component of highaffinity nicotine binding sites (Marks et al., 1992) . Furthermore, in detailed previous studies of midbrain GABAergic neurons, chronic nicotine produced 30-50% increases in a4YFP fluorescence, and this corresponded well with electrophysiologically measured increases in nAChR responses (Nashmi et al., 2007) . Indeed, Nashmi et al. (2007) pointed out that there is a correlation coefficient, across nine brain areas, of 0.91 between the percentage upregulation of fluorescence and the percentage upregulation of nicotine binding (Marks et al., 1992; Nashmi et al., 2007) . As observed here for a4 nAChR subunits, there is often a non-linear or nonmonotonic relation between mRNA expression and protein expression (Fig. 2B) . Overall, the high levels of both a4 mRNA and a4YFP fluorescence suggest that, in the MHb, a4 protein distribution closely parallels the expression of a4 subunit mRNA, and also suggest that the a4 subunit may be functionally incorporated into nAChRs within distinct regions of the MHb.
If a4 subunits normally contribute to receptors in the ventrolateral MHb then one expects cells in this region to produce especially sensitive nicotine responses in mice carrying the a4L9 0 A allele (Tapper et al., 2004 ). This hypothesis was tested by assaying low dose nicotine-induced c-fos expression in vivo and low concentration nicotine-evoked currents in slices.
C-fos activation in the MHb of a4L9
0 A mice
We assessed c-fos expression in brain sections of WT and In a4L9 0 A mice, nicotine injections at doses larger than 0.1 mg/ kg revealed heavier and more widespread c-fos labeling in the MHb (Fig. 4) as well as in other brain regions. Thus, at 10 mg/kg, all regions of the MHb from WT mice showed c-fos labeling (Fig. 4C) . At the intermediate dose of 2 mg/kg, dorsomedial cells of the MHb were still much more heavily labeled in MHb of L9 0 A than of WT mice ( Fig. 4A and B) . These data imply that, in WT mice, despite possible differences in subunit composition, nAChRs in all parts of the ventral MHb are equally sensitive to threshold concentrations of nicotine (see also electrophysiological evidence in Fig. 5 ; Quick et al., 1999) . However, interpretation of data at these higher doses of nicotine is likely complicated by previously reported motor responses such as stereotypy and tremors (Fonck et al., 2005) . Correlations between c-fos expression in the brains of a4L9 0 A mice and the resulting behavioral responses (for example, seizures at 1 mg/kg nicotine) will be the subject of a separate study. Young (P14-P20, similar to animals used for electrophysiology) a4L9 0 A (n ¼ 3) and WT mice (n ¼ 2) were analyzed for c-fos expression in the MHb following a 0.1 mg/kg nicotine injection, revealing a similar expression pattern to that of adult mice (data not shown). (Fig. 5C ). These data are consistent with the inclusion of a4 subunits into functional nAChRs on cells in the ventrolateral but not the ventromedial parts of the MHb.
Discussion
These studies illustrate how genetic approaches using knock-in mice that express fluorescent or hypersensitive nicotinic receptors can help identify the functional contribution of individual subunit mice. Previous data on the two knock-in lines provide ample assurance that neither the hypersensitive L9 0 A mutation nor the introduced YFP moiety alter the expression patterns of a4 * nAChRs or the incorporation of a4 subunits into nAChRs (Tapper et al., 2004 (Tapper et al., , 2007 Fonck et al., 2005; Nashmi et al., 2007; Shao et al., 2008) . Subunit composition analysis based on gain-of-function knock-in may be extended to other nAChR subunit genes or other ligandgated ion channels.
These gain-of-function analyses complement pharmacological studies, especially because there are few agonists, antagonists, or allosteric modulators selective for single nAChR subtypes. The MHb is among a group of brain regions that may not express the otherwise dominant a4b2 * nAChR subtype(s) (Marks et al., 1998; Perry et al., 2002) . Previous studies concluded that a plurality of receptors in this nucleus contains an a3b4 ligand-binding interface, based on the strong potency of cytisine (Mulle and Changeux, 1990) , and the high sensitivity to the a-conotoxin AuIB (Quick et al., 1999) . The present data suggest the presence of an additional component: an a4 * population of nAChRs within the ventrolateral MHb. The c-fos stereology data, combined with the knowledge that the MHb is w1.8 mm in length, allow us to estimate that this population is w7200 neurons per mouse MHb. Which non-a subunit(s) partner with MHb a4 to form functional receptors? The a4b2 subunit combination, widely distributed in the rest of the brain, appears unlikely because b2 knockout mice retain nicotinic responses in MHb (Picciotto et al., 1995) . Given the preponderance of b4 in the MHb, we speculate that a4b4 * receptors predominate in the ventrolateral MHb, while the a3b4 * subtype(s) is more prevalent in the medial MHb.
The a4L9 0 A mice are an exon replacement knock-in strain and do not overexpress receptors. As shown by Tapper et al. (2004) and by Fonck et al. (2005) , a4L9 0 A are present at normal to modestly less than normal levels; non-cytisine-sensitive high-affinity receptors are also present at normal levels. The a4L9 0 A mice develop normally in all respects. While they are hypersensitive to exogenously administered nicotine, ACh itself is eliminated within w1 ms by endogenous acetylcholinesterase. Consistent with these points, previous data show that the a4L9 0 A mice have only subtly changed baseline physiology, such as a dihydro-b-erythroidinesensitive breathing frequency (Shao et al., 2008) . It is therefore unlikely that functional compensation occurs in the medial habenula of the a4L9 0 A strain by alterations in the expression of other receptors or subunits.
Interestingly, the major projections of the ventral part of the MHb to the interpeduncular nucleus (IPN) can be divided roughly in keeping with our suggested distribution of a4 * and non-a4 * receptor subtypes. There is a striking retrograde labeling of the ventrolateral MHb that parallels the fluorescent staining (fr; Fig. 1C ) after the caudal/lateral parts of the IPN are injected with dye (Contestabile and Flumerfelt, 1981 ). This appears to be the dominant MHb projection to the IPN, whereas the more medial cell populations seem to project to the central parts of the IPN (Contestabile and Flumerfelt, 1981) . Thus activation of the different nAChRs in regions of the MHb may be associated with differential activation of the subnuclear regions of the IPN, with a corresponding heterogeneity of physiological and behavioral effects (Morley, 1986 ).
Overall, the functional relevance of the MHb is not well understood, although given the cholinergic phenotype of cells in ventral portions of this nucleus, it is likely to be involved in behavioral processes, such as reward, sleep-wake cycles and learning and memory, that involve the relay of cholinergic information from the forebrain to the midbrain (Woolf and Butcher, 1985; Lecourtier and Kelly, 2007) . Perhaps the differential expression of nAChR subtypes within medial and lateral regions of the MHb, coupled with distinct efferent targets, allows the MHb-IPN system to organize these different behaviors. For example, it is tempting to speculate that the presence of two distinct b4-containing receptors in the medial and lateral MHb may segregate distinct aspects of addiction, e.g., sensitization, drug-seeking and modulation of withdrawal symptoms (Salas et al., 2003 (Salas et al., , 2004 Glick et al., 2006; Taraschenko et al., 2007) .
